Anteilseigner
Matrix Capital Management Co. LP (19,67 %) Eventide Asset Management LLC (16,31 %) Fidelity Management & Research Co. LLC (13,55 %) The Vanguard Group, Inc. (5,98 %) BlackRock Fund Advisors (5,96 %) SSgA Funds Management, Inc. (5,33 %) Citadel Advisors LLC (5,09 %) T. Rowe Price Associates, Inc. (Investment Management) (4,83 %) T. Rowe Price Investment Management, Inc. (4,68 %) Capital Research & Management Co. (International Investors) (3,97 %) Decheng Capital LLC (2,96 %) Federated Global Investment Management Corp. (2,82 %) MPM BioImpact, Inc (2,14 %) Woodline Partners LP (2,03 %) Geode Capital Management LLC (1,84 %) Sofinnova Investments, Inc. (1,71 %) PRIMECAP Management Co. (1,64 %) Verition Fund Management LLC (1,63 %) Tybourne Capital Management (HK) Ltd. (1,35 %)
Kontakt
Zentalis Pharmaceuticals Inc.